Research News and Research

RSS

New article discusses the balance between pain management and drug safety

An article by Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, titled "A Difficult Balance - Pain Management, Drug Safety, and the FDA," appears in the Nov. 26, 2009 issue of The New England Journal of Medicine.

26 Nov 2009

Healthy dietary habits are important for GCA prevention

The gastric cardiac adenocarcinoma (GCA) is a very rare disease. In recent decades, however, the incidence of the GCA has increased dramatically in many Western countries. An increasing trend in GCA is also observed in municipal regions but not in rural regions of China. Another striking feature is the strong male predominance among patients with GCA. Some of the reasons above are still unclear and require further epidemiological investigations.

26 Nov 2009

PULSE urges Government of Ontario to introduce CPR course for school students

The Physicians and Paramedics Urging Life Saving Education (PULSE), wants all Ontarians to be prepared to respond in cases of an emergency requiring the use of CPR.

26 Nov 2009

Canadian Stroke Network receives $19.2M federal grant

The Canadian Stroke Network, one of Canada's Networks of Centres of Excellence, has received $19.2 million from the federal government over three years to support valuable research into stroke, one of the leading causes of death and disability in Canada.

26 Nov 2009

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Dr. Sarit Larisch, Head of the Cell Death Research Laboratory in the University of Haifa's Department of Biology, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

26 Nov 2009

China Sky One Medical passes the ICPBP examination for two of its new products

China Sky One Medical, Inc. ("China Sky One Medical" or "the Company"), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company recently passed the Chinese National Institute for the Control of Pharmaceutical and Biological Products ("ICPBP") examination for two of its new products: its Diagnostic Kit for Human Prostate Specific Antigen (Colloidal Gold) and its Determination Kit for Luteinizing Hormone (Colloidal Gold).

26 Nov 2009

Behavior problems in children with autism can be reduced with a training program for parents

The serious behavior problems that can occur in children with autism and related conditions can be reduced with a treatment plan that includes medication combined with a structured training program for parents, according to Yale University researchers and their colleagues.

26 Nov 2009

Potentially dangerous needlestick injuries often go unreported

Medical students are commonly stuck by needles - putting them at risk of contracting potentially dangerous blood-borne diseases - and many of them fail to report the injuries to hospital authorities, according to a Johns Hopkins study published in the December issue of the journal Academic Medicine.

26 Nov 2009

Dermatologists express strong interest in Stelara, despite concerns

BioTrends Research Group, Inc. released Wave 1 of its LaunchTrends(TM): Stelara report, the first in a multi-phase syndicated market research project tracking the launch of Centocor Ortho-Biotech's Stelara, from product launch through the first six months of availability. Each wave of the report provides quantitative information from 75 unique Dermatologists and qualitative information from a subset of 20.

26 Nov 2009

Patients may not benefit from e-samples of prescription drugs, says UW

Search the Internet to learn about your asthma, high cholesterol or other common disorder, and odds are you'll be directed to a pharmaceutical company-sponsored Web homepage. There you'll often find an offer for a free sample or a one-time discount on a top-selling prescription medication.

25 Nov 2009

Erbitux drug can reverse rare stomach disorder, report researchers

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

25 Nov 2009

Protein mutation can cause a new form of heart failure

Over the course of a lifetime, the heart pumps some 250 million liters of blood through the body. In the order to do this, the muscle fibers of the heart have to be extremely durable. The research group headed by Dr. Wolfgang Rottbauer, vice chair of the Department of Medicine III at Heidelberg University Hospital (Chairman: Prof. Dr. H. A. Katus), has discovered a protein that is responsible for the stability of the smallest muscular unit, the sarcomere.

25 Nov 2009

Study reveals that ghrelin can increase resistance to Parkinson's disease

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience.

25 Nov 2009

Obama issues joint statement with Indian Prime Minister Singh, includes health, agriculture collaboration

President Barack Obama and Indian Prime Minister Manmohan Singh "agreed Tuesday to team up and tackle a checklist of economic, nuclear, security and environmental challenges" as well as collaborate on health and agriculture issues, CNN reports.

25 Nov 2009

WHO investigates cases of H1N1 drug resistance in U.S., Britain

The WHO is looking into reports that patients with "severely suppressed immune systems" in Britain and the U.S. developed resistance Tamiflu, which is used to treat the symptoms of H1N1 (swine flu), a spokesman for the organization said Tuesday, Reuters reports.

25 Nov 2009

Despite gains, HIV/AIDS remains public-health priority, UNAIDS, WHO say

"The U.N. report said 'AIDS continues to be a major public-health priority' and called for more funds to support efforts to curb the epidemic and to distribute lifesaving drugs," the Wall Street Journal reports.

25 Nov 2009

Advanced radiation delivery techniques can reduce TomoTherapy treatment time

TomoTherapy Incorporated announced today that a research study published in the November 11, 2009 International Journal of Radiation Oncology * Biology * Physics -- commonly known as the Red Journal -- indicated that TomoTherapy(SM) treatment times could be reduced by up to 66 percent using advanced radiation delivery techniques.

25 Nov 2009

Simulations Plus launches new version of GastroPlus

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, announces the release of GastroPlus Version 6.1, the latest version of its state-of-the-art software used by pharmaceutical research scientists for simulation of oral absorption, intravenous dosing, pharmacokinetics, and pharmacodynamics.

25 Nov 2009

Agfa HealthCare establishes a healthcare technology institute in Canada

Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, today introduced the Agfa HealthCare Institute - a new initiative leveraging collaborative partnerships with world-class vendors, academic institutions, government and healthcare providers throughout North America to help facilitate innovation in the healthcare technology space.

25 Nov 2009

Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

Cutting-edge technologies are about to enter the marketplace, thanks to a new partnership between Gestion Univalor, Limited Partnership (Univalor) and Cognitive Sensing Inc. (CSI), a privately owned technology company based in Montreal.

25 Nov 2009